HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maurizio Bifulco Selected Research

Coronary Disease (Coronary Heart Disease)

10/2014Statins in neurological disorders: an overview and update.
1/2012Pharmacological actions of statins: a critical appraisal in the management of cancer.
5/2008Potential therapeutic role of statins in neurological disorders.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maurizio Bifulco Research Topics

Disease

76Neoplasms (Cancer)
03/2024 - 06/2002
17Colorectal Neoplasms (Colorectal Cancer)
10/2023 - 09/2003
13Breast Neoplasms (Breast Cancer)
08/2023 - 08/2002
12Multiple Sclerosis
03/2022 - 03/2002
12Colonic Neoplasms (Colon Cancer)
09/2019 - 01/2004
11Neoplasm Metastasis (Metastasis)
08/2023 - 05/2003
9Obesity
02/2015 - 06/2007
8Inflammation (Inflammations)
01/2023 - 02/2009
7Brain Neoplasms (Brain Tumor)
03/2023 - 10/2014
7Glioma (Gliomas)
01/2023 - 06/2015
7Nervous System Diseases (Neurological Disorders)
04/2017 - 05/2008
6Glioblastoma (Glioblastoma Multiforme)
01/2023 - 10/2017
6Pain (Aches)
03/2022 - 03/2002
5Carcinogenesis
03/2023 - 09/2009
5Neurodegenerative Diseases (Neurodegenerative Disease)
01/2023 - 01/2013
4COVID-19
08/2022 - 11/2020
4Thyroid Neoplasms (Thyroid Cancer)
03/2014 - 09/2003
4Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
10/2008 - 01/2004
3Nausea
03/2022 - 04/2007
3Autoimmune Diseases (Autoimmune Disease)
01/2022 - 12/2005
3Dermatitis
07/2017 - 01/2011
3Coronary Disease (Coronary Heart Disease)
10/2014 - 05/2008
3Substance-Related Disorders (Drug Abuse)
12/2010 - 06/2007
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2024 - 01/2022
2Anorexia
03/2022 - 08/2009
2Vomiting
03/2022 - 04/2007
2Virus Diseases (Viral Diseases)
03/2022 - 01/2021
2Infections
01/2021 - 11/2020
2Cystic Fibrosis (Mucoviscidosis)
04/2018 - 06/2011
2Melanoma (Melanoma, Malignant)
01/2018 - 12/2014
2Stroke (Strokes)
01/2016 - 10/2014
2Parkinson Disease (Parkinson's Disease)
01/2016 - 10/2014
2Alzheimer Disease (Alzheimer's Disease)
01/2016 - 10/2014
2Necrosis
09/2009 - 10/2006
1Disease Progression
01/2024
1Skin Diseases (Skin Disease)
01/2024
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2024

Drug/Important Bio-Agent (IBA)

29EndocannabinoidsIBA
01/2024 - 03/2002
28CannabinoidsIBA
01/2024 - 03/2002
17CB1 Cannabinoid Receptor (CB1 Receptor)IBA
12/2015 - 08/2002
15Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
08/2022 - 11/2006
14Mevalonic Acid (Mevalonate)IBA
03/2024 - 03/2009
14Cannabinoid Receptors (Cannabinoid Receptor)IBA
01/2016 - 03/2002
13RimonabantIBA
08/2023 - 10/2004
13anandamide (arachidonylethanolamide)IBA
05/2013 - 03/2002
11Proteins (Proteins, Gene)FDA Link
01/2022 - 12/2005
9EnzymesIBA
11/2021 - 08/2002
7CholesterolIBA
01/2021 - 12/2005
7LipidsIBA
01/2021 - 11/2005
6Adenosine (Adenocard)FDA LinkGeneric
12/2022 - 11/2014
6Terpenes (Terpenoids)IBA
04/2022 - 11/2006
5CannabidiolIBA
01/2024 - 09/2006
5CateninsIBA
09/2021 - 11/2012
52-methylarachidonyl-2'-fluoroethylamideIBA
04/2010 - 09/2003
4CytokinesIBA
03/2024 - 08/2022
4Dronabinol (THC)FDA LinkGeneric
01/2023 - 05/2003
4Messenger RNA (mRNA)IBA
10/2017 - 01/2004
4CB2 Cannabinoid ReceptorIBA
04/2017 - 01/2013
4Lovastatin (Mevacor)FDA LinkGeneric
12/2013 - 11/2006
3DNA (Deoxyribonucleic Acid)IBA
01/2023 - 01/2019
3NucleosidesIBA
01/2022 - 03/2009
3LigandsIBA
01/2018 - 01/2012
3GeranyltranstransferaseIBA
10/2017 - 01/2004
3Croton OilIBA
07/2017 - 01/2011
3Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2016 - 01/2010
3Therapeutic UsesIBA
03/2014 - 12/2005
3fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA
03/2011 - 08/2002
32-methyl-2'-F-anandamideIBA
06/2010 - 05/2007
2Biomarkers (Surrogate Marker)IBA
01/2024 - 01/2022
2Immune Checkpoint ProteinsIBA
01/2024 - 01/2022
2Hormones (Hormone)IBA
01/2023 - 01/2012
2Small Interfering RNA (siRNA)IBA
01/2023 - 01/2018
2SteroidsIBA
01/2023 - 01/2012
2MethyltransferasesIBA
01/2023 - 01/2022
2farnesyl pyrophosphate (farnesyl diphosphate)IBA
11/2021 - 07/2017
2Oxidoreductases (Dehydrogenase)IBA
01/2021 - 06/2010
2Fluorouracil (Carac)FDA LinkGeneric
09/2019 - 01/2016
2Oncogene Proteins (Oncogene Protein)IBA
09/2019 - 09/2003
2TubulinIBA
01/2016 - 08/2013
2G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
05/2013 - 11/2005
2Fatty Acid Synthases (Fatty Acid Synthase)IBA
02/2011 - 01/2006
2Fatty Acids (Saturated Fatty Acids)IBA
02/2011 - 08/2002
2Antineoplastic Agents (Antineoplastics)IBA
10/2010 - 11/2007
2Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA
06/2010 - 05/2008
2Estrogens (Estrogen)FDA Link
01/2008 - 12/2005
2arvanilIBA
02/2006 - 03/2002
1Pyruvate KinaseIBA
03/2024
1Indicators and Reagents (Reagents)IBA
01/2024
1AutoantibodiesIBA
01/2024
1Programmed Cell Death 1 ReceptorIBA
01/2024
1Epidermal Growth Factor (EGF)IBA
10/2023
1ChemokinesIBA
08/2023
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
08/2023
1Environmental Pollutants (Pollutants, Environmental)IBA
03/2023
1Environmental CarcinogensIBA
03/2023
1MutagensIBA
03/2023
1Recombinant DNA (Recombinant DNA Research)IBA
03/2023
1AntioxidantsIBA
01/2023

Therapy/Procedure

19Therapeutics
12/2022 - 06/2002
6Drug Therapy (Chemotherapy)
03/2022 - 09/2006